Regulation of opioid receptor activities

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 2, 1999, Pages 607-624

  Law, Ping Yee ^a   Loh, Horace H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; DELTORPHIN; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ETORPHINE; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOBUTYLMETHYLXANTHINE; KAPPA OPIATE RECEPTOR; KT 5720; MORPHICEPTIN[3 (N METHYLPHENYLALANINE) 4 DEXTRO PROLINAMIDE]; MU OPIATE RECEPTOR; NALOXONE; NALTRIBEN; NERVE GROWTH FACTOR; OPIATE AGONIST; OXYMORPHONE; RECEPTOR SUBTYPE; TYROSYL (1,2,3,4 TETRAHYDROISOQUINOLINE 3 CARBOXYLIC ACID PHENYLAMIDE)PHENYLALANYLPHENYLALANINE; UNCLASSIFIED DRUG;

CONCENTRATION RESPONSE; CONFERENCE PAPER; DRUG BINDING SITE; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; DRUG TOLERANCE; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

ANIMALS; DOWN-REGULATION; GTP-BINDING PROTEINS; HUMANS; PHOSPHORYLATION; RECEPTORS, OPIOID; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 0032901479     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (128)

1. Abood ME and Tao Q (1995) Characterization of a delta opioid receptor in rat pheochromocytoma cells. J Pharmacol Exp Ther 274:1566-1573.
2. Arden JR, Segredo V, Wang Z, Lameh J and Sadee W (1995) Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. J Neurochem 65:1636-1645.
3. Augustine LB, Felsheim RF, Min BH, Fuchs SM, Fuchs JA and Loh HH (1995) Genomic structure of mouse δ opioid receptor gene. Biochem Biophys Res Commun 207:111-119.
4. Bhargava H and Gulati A (1990) Down-regulation of brain and spinal cord μ-opiate receptors in morphine tolerant-dependent rats. Eur J Pharmacol 190:305-311.
5. Brady L, Herkenham M, Long J and Rothman R (1989) Chronic morphine increases μ-opioid receptor binding in rat brain: A quantitative autoradiographic study. Brain Res 477:382-386
6. 363 as the amino acids involved in etorphine-induced down-regulation of the mu-opioid receptor. J Biol Chem 273:34488-3449.
7. Capeyrou R, Riond J, Corbani M, Lepage JF, Bertin B and Emorine LJ (1997) Agonist-induced signaling and trafficking of the mu-opioid receptor: Role of serine and threonine residues in the third cytoplasmic loop and C-terminal domain. FEBS Lett 415:200-205.
8. Carter BD and Medzihradsky F (1993) Go mediates the coupling of the μ opioid receptor to adenylyl cyclase in cloned neural cells and brains. Proc Natl Acad Sci USA 90:4062-4066.
9. Chabry J, Botto JM, Nouel D, Beaudet A, Vincent JP and Mazella J (1995) Thr-422 and Tyr-424 residues in the carboxyl terminus are critical for the internalization of the rat neurotensin receptor. J Biol Chem 270:2439-2442.
10. Chakrabarti S, Law PY and Loh HH (1995a) Neuroblastoma Neuro2A cells stably expressing a cloned μ-opioid receptor: A specific cellular model to study acute and chronic effectors of morphine. Mol Brain Res 30:269-278.
11. 32P-α-azidoanilido GTP labeling of multiple G protein α-subunits. J Neurochem 64: 2354-2543.
12. Chakrabarti S, Yang W, Law PY and Loh HH (1997) The μ-opioid receptor down-regulates differently from the δ-opioid receptor: Requirement of a high affinity receptor-G-protein complex formation. Mol Pharmacol 52:105-113.
13. Chang KJ and Cuatrecasas P (1979a) Multiple opiate receptors: Enkephalins and morphine bind to receptors of different specificity. J Biol Chem 254:2610-2618.
14. Chang KJ, Cooper BR, Hazum E and Cuatrecasas P (1979b) Multiple opiate receptors: Different regional distribution in the brain and differential binding of opiates and opioid peptides. Mol Pharmacol 16:91-104.
15. Chang KJ, Eckel R and Blanchard S (1982) Opioid peptide induced reduction of enkephalin receptors in cultured neuroblastoma cells. Nature 296:446-448.
16. +channel. J Biol Chem 269:7839-7842.
17. Chen Y, Mestek A, Liu J, Hurley JA and Yu L (1993b) Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol Pharmacol 44:8-12.
18. Chen Y, Mestek A, Liu J and Yu L (1993a) Molecular cloning of a rat κ opioid receptor reveals sequence similarities to the μ and δ opioid receptors. Biochem J 295:625-628.
19. Choe CY, Im HJ, Ko JL and Loh HH (1998) Mouse μ opioid receptor gene expression: A 34-bp cis-acting element inhibits transcription of the mu-opioid receptor gene from the distal promoter. J Biol Chem 273:34926-34932.
20. Christophe D and Pichon B (1994) DNA methylation and gene activity: Towards the end of the debate. Mol Cell Endocrinol 100:155-158.
21. Chu P, Murray S, Lissin D and Von Zastrow M (1997) δ and κ opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. J Biol Chem 272:27124-27130.
22. Chuang LF, Chuang TK, Killam KF, Chuang AJ, Kung H, Yu L and Chuang RY (1994) Delta opioid receptor gene expression in lymphocytes. Biochem Biophys Res Commun 202:1291-1299.
23. Claude PA, Wotta DR, Zhang XH, Prather PL, Mcginn TM, Erickson LJ, Loh HH and Law PY (1996) Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonist. Proc Natl Acad Sci USA 93:5715-5719.
24. Comb M and Goodman H (1990) CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res 18: 3975-3982.
25. Costa T and Herz A (1989) Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci USA 86: 7321-7325.
26. Cotecchia S, Costa T and Lefkowitz RJ (1993) A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 268:4625-4636.
27. Creese I and Snyder S (1975) Receptor binding and pharmacological activity in guinea pig intestine. J Pharmacol Exp Ther 194:205-219.
28. Cvejic S and Devi LA (1997) Dimerization of the δ opioid receptor: Implication for a role in receptor internalization. J Biol Chem 272:26959-26964.
29. Cvejic S, Trapaidze N, Cyr C and Devi L (1996) Thr353, located within the COOH-terminal tail of the δ opiate receptor, is involved in receptor down-regulation. J Biol Chem 271:4073-4076.
30. El Kouhen R, Maestri-El Houhen O, Law PY and Loh HH (1999) The absence of a direct correlation between the loss of DAMGO inhibition of adenylyl cyclase activity and agonist-induced mu-opioid receptor phosphorylation. J Biol Chem, in press.
31. Evans CJ, Keith DE, Morrison H, Magendzo K and Edwards RH (1992) Cloning of a delta opioid receptor by functional expression. Science 258:1952-1955.
32. Field TA, Linder ME and Casey PJ (1994) Subtype-specific binding of azidoanilido-GTP by purified G protein α subunits. Biochemistry 33:6877-6883.
33. Fukuda K, Kato S and Mori K (1995) Location of regions of the opioid receptor involved in selective agonist binding. J Biol Chem 270:6702-6709.
34. Fukuda K, Kato S, Mori K, Hishi M and Takeshima H (1993) Primary structures and expression from cDNAs of rat opioid receptor δ- and μ-subtypes. FEBS Lett 327:311-314.
35. Fukuda K, Kato S, Morikawa H, Shoda T and Mori K (1996) Functional coupling of the δ-, μ- and κ-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J Neurochem 67:1309-1316.
36. Garzon J, Martinez-Pena Y and Sanchez-Blazquez P (1997) Gx/z is regulated by mu but not delta opioid receptors in the stimulation of the low Km GTPase activity in mouse periaqueductal grey matter. Eur J Neurosci 9:1194-1200.
37. Goldstein A, Tachibana S, Lowney LI, Hunkapiller M and Hood L (1979) Dynorphin (1-13), an extraordinarily potent opioid peptide. Proc Natl Acad Sci USA 76:6666-6669.
38. Gylys KH, Tran N, Magendzo K, Zaki P and Evans CJ (1997) cAMP decreases steady-state levels of delta-opioid receptor mRNA in NG108-15 cells. NeuroReport 8:2369-2372.
39. Harhammer R, Gohla A and Schultz G (1996) Interaction of G protein βγ dimers with small GTP-binding proteins. FEBS Lett 399:211-214.
40. 2AR through receptor dimerization. Biochem J 330:287-293.
41. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 271:16384-16392.
42. Henry DJ, Grandy DK, Lester HA, Davidson N and Chavkin C (1995) K-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes. Mol Pharmacol 47:551-557.
43. Hescheler J, Rosenthal W, Trautwein W and Schultz G (1987) The GTP-binding protein Go, regulates neuronal calcium channels. Nature 325:445-446.
44. Hollt V, Dum J, Blasig J, Schubert P and Herz A (1975) Comparison of in vivo and in vitro parameters of opiate receptor binding in native and tolerant/dependent rodents. Life Sci 16:1823-1828.
45. Hughes J, Smith TW, Kolsterlitz HW, Fothergill LA, Morgan BA and Morris HR (1975) Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258:577-579.
46. Imagawa M, Chiu R and Karin M (1987) Transcription factor AP2 mediates induction by two different signal transduction pathways: Protein kinase C and cAMP. Cell 51:251-60.
47. Inoue N and Hatanak H (1982) Nerve growth factor induces specific enkephalin binding sites in a nerve cell line. J Biol Chem 257:9238-9241.
48. James IF, Chavkin C and Goldstein A (1982) Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin. Proc Natl Acad Sci USA 79:7570-7574.
49. Janovich JA and Conn PM (1996) Gonadtropin releasing hormone agonist provokes homologous receptor microaggregation: an early event in seven-transmembrane receptor mediated signaling. Endocrinology 137:3602-3605.
50. Johnson PS, Wang JB, Wang WF and Uhl GR (1994) Expressed mu opioid receptor couples to adenylate cyclase and phosphatidyl inositol turnover. NeuroReport 5:507-509.
51. Kaufman DL, Keith DE, Anton B, Tian J, Magendzo K, Newman D, Tran TH, Lee DS, Wen C, Xia YR, Lusis AJ and Evans CJ (1995) Characterization of murine μ-opioid receptor gene J Biol Chem 270:15877-15883.
52. Kieffer BL, Befort K, Gaveriaux-Ruff C and Hirth CG (1992) The δ-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA 89:12048-12052.
53. Klee WA and Streaty RA (1974) Narcotic receptor sites in morphine-dependent rats. Nature 248:61-63.
54. Ko JL, Liu HC, Minnerath SR and Loh HH (1998) Transcriptional regulation of mouse μ-opioid receptor gene. J Biol Chem 273:27678-27685.
55. Ko JL, Minnerath SR and Loh HH (1997) Dual promoters of mouse μ-opioid receptor gene. Biochem Biophys Res Commun 234:351-357.
56. Koch T, Schulz S, Schroder H, Wolf R, Raulf E and Hollt V (1998) Carboxyl-terminal splicing of the rat μ opioid receptor modulates agonist-mediated internalization and receptor resensitization. J Biol Chem 273:13652-13657.
57. Kong HY, Raynor K, Yasuda K, Moe ST, Portoghese PS, Bell GI and Reisine T (1993) A single residue, aspartic acid 95, in the δ opioid receptor specifies selective high affinity agonist binding. J Biol Chem 268:23055-23058.
58. Kovoor A, Nappey V, Kieffer BL and Chavkin C (1997) μ and δ opioid receptors are differentially desensitized by the coexpression of β-adrenergic receptor kinase 2 and β-arrestin 2 in Xenopus oocytes. J Biol Chem 272:27605-27611.
59. Kraus J, Horn G, Zimprich A, Simon T, Mayer P and Hollt V (1995) Molecular cloning and functional analysis of the rat mu opioid receptor gene promoter. Biochem Biophys Res Commun 215:591-597.
60. Krupnick JG and Benovic JL (1998) The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Ann Rev Pharmacol Toxicol 38:289-319.
61. Kunsch C, Lang RK, Rosen CA and Shannon MF (1994) Synergistic transcriptional activation of the IL-8 gene by NF-kB p65 (RelA) and NF-IL-6. J Immunol 153: 153-164.
62. Law SF and Reisine T (1997) Changes in the association of G protein subunits with the cloned mouse delta opioid receptor on agonist stimulation. J Pharmacol Exp Ther 281:1476-1486.
63. Law PY, Hom DS and Loh HH (1982) Loss of opiate receptor activity in neuroblastoma x glioma NG108-15 hybrid cells after chronic opiate treatment: A multiple step process. Mol Pharmacol 22:1-4.
64. Law PY, Hom DS and Loh HH (1983a) Down-regulation of opiate receptor in neuroblastoma x glioma NG108-15 hybrid cells: chloroquine promotes accumulation of triated enkephalin in the lysosomes. J Biol Chem 259:4096-4104.
65. Law PY, Hom DS and Loh HH (1983b) Opiate receptor down-regulation and desensitization in neuroblastoma x glioma NG108-15 hybrid cells are two separate cellular adaptation process. Mol Pharmacol 24:413-424.
66. Law PY, Louie AK and Loh HH (1985a) Effect of pertussis toxin treatment on the down-regulation of opiate receptors in neuroblastoma x glioma NG108-15 hybrid cells. J Biol Chem 260:14818-14823.
67. Law PY, Ungar HG, Hom DS and Loh HH (1985b) Effects of cycloheximide and tunicamycin on opiate receptor activities in neuroblastoma x glioma NG108-15 hybrid cells. Biochem Pharmacol 34:9-17.
68. 16-mediated stimulation of phospholipase C. J Neurochem 70:2203-2211.
69. Lefkowitz RJ (1998) G-protein coupled receptors. III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization. J Biol Chem 273:18677-18680.
70. Lelander JD (1983) A kappa opioid effect: Increase urination in the rat. J Pharmacol Exp Ther 224:89-94.
71. Leventhal L, Silva RM, Rossi GC, Pasternak GW and Bodnar RJ (1998) Morphine-6-β-glucuronide-induced hyperphagia: Characterization of opioid action by selective antagonists and antisense mapping in rats. J Pharmacol Exp Ther 287:538-544.
72. Li CH and Chung D (1976) Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands. Proc Natl Acad Sci USA 73:1145-1148.
73. Li LY and Chang KJ (1996) The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express μ-opioid receptors. Mol Pharmacol 50:599-602.
74. Li S, Zhu J, Chen C, Chen YW, Deriel JK, Ashby B and Liu-Chen LY (1993) Molecular cloning and expression of a rat κ opioid receptor. Biochem J 295:629-633.
75. Liang Y, Mestek A, Yu L and Carr LG (1995) Cloning and characterization of the promoter region of the mouse mu opioid receptor gene. Brain Res 679:82-88.
76. Liu HC, Lu S, Augustin LB, Felsheim RF, Chen HC, Loh HH and Wei LN (1995) Cloning and promoter mapping of mouse κ opioid receptor gene. Biochem Biophys Res Commun 209:639-47.
77. Loh HH, Liu HC, Cavalli A, Yang W, Chen YF and Wei LN (1998) μ opioid receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality. Mol Brain Res 54:321-326.
78. Luo X, Zhang D and Weinstein H (1994) Ligand-induced domain motion in the activation mechanism of a G-protein-coupled receptor. Protein Eng 7:1441-1448.
79. Maggio R, Barbier P, Fornai F and Corsini GU (1996) Functional role of the third cytoplasmic loop in muscarinic receptor dimerization. J Biol Chem 271:31055-31060.
80. Marjamaki A, Sato M, Bouet-Alard R, Yang Q, Limon-Boulez I, Legrand C and Lanier SM (1997) Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptor. Interaction of stimulatory and inhibitory input to the effector adenylyl cyclase. J Biol Chem 272:16466-16473.
81. Martin WR, Eades CG, Thompson JA, Huppler RE and Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517-532.
82. Matthes HWD, Maldonaldo R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolles P, Tzavara E, Hanoune J, Roques BP and Kieffer BL (1996) Loss of morphine induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ opioid receptor gene. Nature 383:819-823.
83. McKenzie FR and Milligan G (1990) δ-Opioid receptor mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2. Biochem J 267:391-398.
84. Meng F, Xie GX, Thompson RC, Mansour A, Goldstein A, Watson SJ and Akil H (1993) Cloning and pharmacological characterization of a rat kappa-opioid receptor. Proc Natl Acad Sci USA 90:9954-9958.
85. Michell R, McCullock D, Lutz E, Johnson M, MacKenzie C, Fennell M, Fink G, Zhou W and Sealfon SC (1998) Rhodopsin-family receptors associated with small G proteins to activate phospholipase D. Nature 392:411-414.
86. Milligan G and McKenzie FR (1988) Opioid peptides promote cholera toxin catalyzed ADP-ribosylation of the inhibitory guanine-nucleotide-binding protein (Gi) in membranes of neuroblastoma x glioma hybrid cells. Biochem J 252:369-373.
87. Min BH, Augustin LB, Felsheim RF, Fuchs JA and Loh HH (1994) Genomic structure and analysis of promoter sequence of a mouse μ opioid receptor gene. Proc Natl Acad Sci USA 91:9081-85.
88. Minami M, Onogi T, Nakagawa T, Katao Y, Aoki Y, Katsumata S and Satoh M (1995) DAMGO a μ-opioid receptor selective ligand distinguishes between μ- and κ-opioid receptors at the different region from that for the distinction between μ- and δ-opioid receptors. FEBS Lett 364:23-27.
89. Mitchell PJ, Timmons PM, Hebert JM, Riby PWJ and Tijian R (1991) Transcription factor AP2 is expressed in neural crest cell linkages during mouse embryogenesis. Genes Dev 5:105-119.
90. Ng GY, O'Dowd BF, Lee SP, Chung HT, Brann MR, Seeman P and George SR (1996) Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem Biophys Res Commun 227:200-204.
91. Pak Y, Kouvelas A, Scheideler MA, Rasmussen J, O'Dowd BF and George SR (1996) Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein. Mol Pharmacol 50:1214-1222.
92. Pak Y, O'Dowd BF and George SR (1997) Agonist-induced desensitization of the μ opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal tail. J Biol Chem 272:24961-24965.
93. Pawson T and Scott JD (1997) Signaling through scaffold, anchoring and adaptor proteins. Science 278:2075-2080.
94. Pei G, Keiffer BL, Lefkowitz RJ and Freedman NJ (1995) Agonist-dependent phosphorylation of the mouse δ-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C. Mol Pharmacol 48:173-177.
95. Pepin MC, Yue SY, Roberts E, Wahlestedt C and Walker P (1997) Novel "restoration of function" mutagenesis strategy to identify amino acids of the δ-opioid receptor involved in ligand binding. J Biol Chem 272:9260-9267.
96. Pert C and Snyder S (1973) Opiate receptor demonstration in nervous tissue. Science 179:1011-1014.
97. +2 channel and adenylyl cyclase modulation by cloned μ-opioid receptors in GH3 cells. Mol Pharmacol 47:1041-1049.
98. +2 channels by cloned μ- and δ-opioid receptors. Mol Pharmacol 50:947-956.
99. Porreca F, Cowan A, Raffa RB, Tallarida RJ (1982) Tolerance and cross-tolerance studies with morphine and ethylketocyclazocine. J Pharm Pharmacol 34:666-667.
100. Prather PL, Loh HH and Law PY (1994b) Interaction of δ-opioid receptors with multiple G-proteins: A non-relationship between agonist potency to inhibit adenylyl cyclase and activation of G-proteins. Mol Pharmacol 45:997-1003.
101. Prather PL, McGinn TM, Claude PA, Liu-Chen LY, Loh HH and Law PY (1995) Properties of κ-opioid receptor expressed in CHO cells: Activation of multiple G-proteins similar to other opioid receptors. Mol Brain Res 29:336-346.
102. Prather PL, McGinn TM, Erickson J, Evans CJ, Loh HH and Law P (1994a) Ability of δ-opioid receptors to interact with multiple G-proteins is independent of receptor density. J Biol Chem 269:21293-21302.
103. Pronin AN, Satpaev DK, Slepak VZ and Benovic JL (1997) Regulation of G protein-coupled receptor kinases by calmodulin and localization of the calmodulin binding domain. J Biol Chem 272:18273-18280.
104. Robson LE and Kosterlitz HW (1979) Specific protection of the binding sites of D-A12-D-leu5-enkephlain (delta-receptors) and dihydromorphine (mu-receptor). Proc R Soc Lond B Biol Sci 205:425-432.
105. Rothman R, Danks J, Jacobson A, Burke TJ, Rice K, Tortella F and Holaday J (1986) Morphine tolerance increases mu-noncompetitive delta binding sites. Eur J Pharmacol 124:113-119.
106. Roy S, Liu HC and Loh HH (1998a) μ-Opioid receptor-knockout mice: The role of μ-opioid receptor in gastrointestinal transit. Mol Brain Res 56:281-283.
107. Roy S, Barke RA and Loh HH (1998b) Mu-opioid receptor-knockout mice: Role of μ-opioid receptor in morphine mediated immune functions. Mol Brain Res 61:190-194.
108. Saffer JD, Jackson SP and Annarella MB (1991) Developmental expression of Sp1 in the mouse. Mol Cell Biol 11:2189-2199.
109. Schultz R, Wuster M, Krenss H and Herz A (1980) Selective development of tolerance without dependence in multiple opiate receptors of mouse vas deferens. Nature 285:242-243.
110. Simon E, Hiller J and Edelman I (1973) Stereospecific binding of the potent narcotic analgesic 3H-etorphine to rat brain homogenate. Proc Natl Acad Sci USA 70: 1947-1951.
111. Sora I, Takahashi N, Funadz M, Ujike H, Revay RS, Donovan DM, Miner LL and Uhl GR (1997) Opioid receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci USA 94:1544-1549.
112. +2 from intracellular stores in transfected neuro2a cells by activation of multiple opioid receptor subtypes. Biochem Pharmacol 54:809-818.
113. Surratt CK, Johnson PS, Moriwaki A, Seidleck BK, Blaschak CJ, Wang JB and Uhl GR (1994) μ-Opioid receptor: Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J Biol Chem 269:20548-20553.
114. Tallent M, Dichter MA, Bell GI and Reisine T (1994) The cloned kappa opioid receptor couples to an N-type calcium current in undifferentiated PC-12 cells. Neuroscience 63:1033-40.
115. 5]enkephalin treatment. Brain Res 462: 313-320.
116. Tao PL, Law PL and Loh HH (1987) Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment. J Pharmacol Exp Ther 240:809-816.
117. Tao PL, Lee HY, Chang LR and Loh HH (1990) Decrease in μ-opioid receptor binding capacity in rat brain after chronic PL017 treatment. Brain Res 526: 270-275.
118. Terenius L (1973) Characteristics of the receptor for narcotic analgesics in synaptic plasma membrane fraction from rat brain. Acta Pharacol Toxicol 33:317-320.
119. Tian M, Fan HEB, Lai Z, Zhang S, Aronica S, Cooper S, Bigsby RM, Steinmetz R, Engle SJ, Mestek A, Pollock JD, Lehman MN, Jansen HT, Ying M, Stambrook PJ, Tischfield JA and Yu L (1997) Altered hemotopoiesis, behavior and sexual function in μ opioid receptor deficient mice. J Exp Med 185:1517-1522.
120. Trapaidze N, Keith DE, Cvejic S, Evans CJ and Devi LA (1996) Sequestration of the δ-opioid receptor. Role of the C terminus in agonist-mediated internalization. J Biol Chem 271:29279-29285.
121. Tsunoda S, Sierralta J, Sun Y, Bodner R, Suzuki E, Becker A, Socolich M and Zuker CS (1997) A multivalent PDZ-domain protein assembles signaling complexes in a G protein-coupled cascade. Nature 388:243-249.
122. Venema RC, Ju H, Venema VJ, Schieffer B, Harp JB, Ling BN, Eaton DC and Marrero MB (1998) Angiotensin II-induced association of phospholipase Cγ1 with the G-protein coupled AT1 receptor. J Biol Chem 273:7703-7708.
123. Wang WW, Shahrestanifar M, Jin J and Howells R (1995) Studies on μ and δ opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. Proc Natl Acad Sci USA 92:12436-12440.
124. Werling L, McMahon P and Cox B (1989) Selective changes in μ-opioid receptor properties induced by chronic morphine exposure. Proc Natl Acad Sci USA 86: 6393-6397.
125. Xue JC, Chen C, Zhu J, Kunapuli SP, de Rie JK, Yu L and Liu-Chen LY (1995) The third extracellular loop of the m opioid receptor is important for agonist selectivity. J Biol Chem 270:12977-12979.
126. Yasuda Y, Raynor K, Kong H, Breder CD, Takeda J, Reisine T and Bell GI (1993) Cloning and functional comparison of κ and δ opioid receptors from mouse brain. Proc Natl Acad Sci USA 90:6736-6740.
127. Yu Y, Zhang L, Yin X, Sun H, Uhl GR and Wang JB (1997) Mu opioid receptor phosphorylation, desensitization and ligand efficacy. J Biol Chem 272:28869-28874.
128. Zhang J, Ferguson SSG, Barak LS, Bodduluri S, Laporte S, Law PY and Caron MG (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of μ-opioid receptor responsiveness. Proc Natl Acad Sci USA 95:7157-7162.